Invesco
NEO icon

Invesco’s NeoGenomics NEO Stock Holding History

Invesco’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.17M Buy
562,465
+23,308
+4% +$245K ﹤0.01% 2267
2025
Q4 		$6.34M Sell
539,157
-21,216
-4% -$229K ﹤0.01% 2120
2025
Q3 		$4.33M Buy
560,373
+85,250
+18% +$597K ﹤0.01% 2292
2025
Q2 		$3.47M Buy
475,123
+41,960
+10% +$339K ﹤0.01% 2360
2025
Q1 		$4.11M Buy
433,163
+22,196
+5% +$277K ﹤0.01% 2253
2024
Q4 		$6.77M Sell
410,967
-27,789
-6% -$432K ﹤0.01% 2079
2024
Q3 		$6.47M Sell
438,756
-42,431
-9% -$664K ﹤0.01% 2073
2024
Q2 		$6.67M Sell
481,187
-35,984
-7% -$510K ﹤0.01% 2032
2024
Q1 		$8.13M Sell
517,171
-1,177,288
-69% -$18.2M ﹤0.01% 1935
2023
Q4 		$27.4M Sell
1,694,459
-64,676
-4% -$1.06M 0.01% 1261
2023
Q3 		$21.6M Buy
1,759,135
+44,180
+3% +$657K 0.01% 1295
2023
Q2 		$27.6M Sell
1,714,955
-145,483
-8% -$2.4M 0.01% 1191
2023
Q1 		$32.4M Buy
1,860,438
+1,267,937
+214% +$18.1M 0.01% 1134
2022
Q4 		$5.47M Sell
592,501
-723,792
-55% -$6.75M ﹤0.01% 2203
2022
Q3 		$11.3M Sell
1,316,293
-23,755
-2% -$236K ﹤0.01% 1710
2022
Q2 		$10.9M Buy
1,340,048
+13,199
+1% +$126K ﹤0.01% 1784
2022
Q1 		$16.1M Sell
1,326,849
-2,421,774
-65% -$51M ﹤0.01% 1651
2021
Q4 		$128M Sell
3,748,623
-259,341
-6% -$10.2M 0.03% 700
2021
Q3 		$193M Sell
4,007,964
-485,987
-11% -$22.5M 0.05% 516
2021
Q2 		$203M Sell
4,493,951
-330,014
-7% -$14.6M 0.05% 519
2021
Q1 		$233M Sell
4,823,965
-567,602
-11% -$29.6M 0.06% 404
2020
Q4 		$290M Buy
5,391,567
+243,036
+5% +$11M 0.08% 291
2020
Q3 		$190M Buy
5,148,531
+774,895
+18% +$28.8M 0.06% 377
2020
Q2 		$135M Buy
4,373,636
+511,828
+13% +$14.2M 0.05% 481
2020
Q1 		$107M Buy
3,861,808
+1,565,935
+68% +$46.9M 0.04% 481
2019
Q4 		$67.2M Buy
2,295,873
+851,060
+59% +$20.3M 0.02% 861
2019
Q3 		$27.6M Sell
1,444,813
-47,072
-3% -$1.1M 0.01% 1226
2019
Q2 		$32.7M Sell
1,491,885
-148,170
-9% -$3.25M 0.01% 1199
2019
Q1 		$33.6M Buy
1,640,055
+1,557,319
+1,882% +$27.1M 0.01% 987
2018
Q4 		$1.04M Sell
82,736
-5,652
-6% -$84.2K ﹤0.01% 2951
2018
Q3 		$1.36M Buy
88,388
+15,219
+21% +$210K ﹤0.01% 2987
2018
Q2 		$959K Buy
73,169
+5,021
+7% +$55.3K ﹤0.01% 3158
2018
Q1 		$556K Buy
68,148
+33,709
+98% +$273K ﹤0.01% 3286
2017
Q4 		$305K Buy
34,439
+210
+0.6% +$1.94K ﹤0.01% 3441
2017
Q3 		$381K Buy
34,229
+1,537
+5% +$15K ﹤0.01% 3383
2017
Q2 		$293K Buy
+32,692
New +$259K ﹤0.01% 3495
2016
Q4 		– Sell
-123,819
Closed -$1.02M – 3697
2016
Q3 		$1.02M Buy
123,819
+13,798
+13% +$116K ﹤0.01% 2942
2016
Q2 		$885K Sell
110,021
-37,436
-25% -$300K ﹤0.01% 2969
2016
Q1 		$994K Sell
147,457
-141,932
-49% -$934K ﹤0.01% 2919
2015
Q4 		$2.28M Sell
289,389
-721
-0.2% -$5.28K ﹤0.01% 2440
2015
Q3 		$1.66M Buy
290,110
+241,692
+499% +$1.5M ﹤0.01% 2626
2015
Q2 		$262K Buy
+48,418
New +$250K ﹤0.01% 3623

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Invesco's NEO Position: Q1 2026 in Review

Invesco increased its NeoGenomics (NEO) stake by 4.3% in Q1 2026, buying an estimated $245K and bringing the position to 562,465 shares worth $4.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2267.

Invesco first reported a position in NEO in Q2 2015 and has held it in 42 quarters since. The position peaked at $290M in Q4 2020. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Invesco held 562,465 shares of NeoGenomics worth $4.17M as of Q1 2026.
  • Invesco bought 23,308 NeoGenomics shares in Q1 2026, an estimated $245K.
  • NeoGenomics made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2267 holding.
  • Invesco first reported a position in NeoGenomics in Q2 2015 and has held it in 42 quarters since.
  • Invesco's NeoGenomics position peaked at $290M in Q4 2020.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.